Search

everythinglearnresearchcommunity

for

Search:↓

Bicalutamide may help treat female pattern hair loss.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Testosterone pellets might work for transgender men's hormone therapy, but more research is needed.

Minoxidil can help transgender males grow facial hair before starting testosterone therapy.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.

Air Vice-Marshal Sir Ralph Jackson significantly advanced dialysis technology in the UK.

Ginseng and Albizia extracts help prevent hair thinning with age.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

The document suggests medicine should integrate biological and cultural factors and focus on holistic, equitable care.

The 11th AICPE Congress in Rimini was a major event in European aesthetic plastic surgery.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.